HEALTH CATALYST INC's ticker is HCAT and the CUSIP is 42225T107. A total of 109 filers reported holding HEALTH CATALYST INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 1.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,228 | -15.9% | 121,385 | +3.9% | 0.00% | 0.0% |
| Q2 2023 | $1,460 | +12.0% | 116,786 | +4.5% | 0.00% | 0.0% |
| Q1 2023 | $1,304 | +32.3% | 111,771 | +20.5% | 0.00% | +100.0% |
| Q4 2022 | $986 | -99.9% | 92,723 | +19.3% | 0.00% | 0.0% |
| Q3 2022 | $754,000 | -28.5% | 77,717 | +6.8% | 0.00% | 0.0% |
| Q2 2022 | $1,055,000 | -42.4% | 72,778 | +3.7% | 0.00% | -50.0% |
| Q1 2022 | $1,833,000 | -20.8% | 70,161 | +20.1% | 0.00% | 0.0% |
| Q4 2021 | $2,315,000 | +32.9% | 58,440 | +67.8% | 0.00% | 0.0% |
| Q3 2021 | $1,742,000 | -23.5% | 34,834 | -15.1% | 0.00% | 0.0% |
| Q2 2021 | $2,278,000 | +61.8% | 41,045 | +36.4% | 0.00% | 0.0% |
| Q1 2021 | $1,408,000 | +7.5% | 30,100 | 0.0% | 0.00% | +100.0% |
| Q4 2020 | $1,310,000 | +21.0% | 30,100 | +1.7% | 0.00% | 0.0% |
| Q3 2020 | $1,083,000 | +25.5% | 29,600 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $863,000 | +371.6% | 29,600 | +322.9% | 0.00% | – |
| Q1 2020 | $183,000 | -24.7% | 7,000 | 0.0% | 0.00% | – |
| Q4 2019 | $243,000 | +20.3% | 7,000 | +9.4% | 0.00% | – |
| Q3 2019 | $202,000 | – | 6,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Daventry Group, LP | 1,439,614 | $15,303,097 | 13.21% |
| Nepsis Inc. | 982,281 | $10,441,647 | 3.50% |
| Numerai GP LLC | 322,906 | $3,432,491 | 2.34% |
| Prosight Management, LP | 347,724 | $3,696,306 | 2.02% |
| First Light Asset Management, LLC | 1,161,995 | $12,352,007 | 1.15% |
| CVS HEALTH Corp | 32,273 | $343,057 | 0.30% |
| Bullseye Asset Management LLC | 47,031 | $500 | 0.27% |
| Granahan Investment Management | 809,485 | $8,604,826 | 0.26% |
| Rock Springs Capital Management LP | 929,900 | $9,884,837 | 0.24% |
| Rhenman & Partners Asset Management AB | 180,000 | $1,913,400 | 0.20% |